v3.26.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
 3 Months Ended 12 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Dec. 31, 2025
Operating activities:      
Net income (loss) $ 9,218 $ (23,735)  
Adjustments to reconcile net income (loss) to net cash used in operating activities:      
Depreciation 281 290  
Non-cash interest expense 65 79  
Non-cash operating lease expense 424 382  
Stock-based compensation expense 2,531 1,406  
Change in fair value of warrant liabilities (30,055) (825)  
Change in fair value of notes payable, non-cash (450) (777)  
Changes in operating assets and liabilities:      
Inventory   73  
Prepaid expenses and other current assets (774) (665)  
Accounts payable 75 (1,761)  
Accrued expenses and other current liabilities (2,929) 780  
Operating lease liabilities (379) (298)  
Other long-term assets and liabilities (484) (28)  
Net cash used in operating activities (22,477) (25,079)  
Investing activities:      
Purchases of property and equipment   (448)  
Net cash used in investing activities   (448)  
Financing activities:      
Proceeds from exercise of stock options   280  
Proceeds from common stock warrants 4,058    
Proceeds from issuance of common stock under employee stock purchase plan 170    
Principal payments on finance lease obligations (123) (109)  
Net cash provided by financing activities 4,105 171  
Net increase (decrease) in cash, cash equivalents and restricted cash (18,372) (25,356)  
Cash, cash equivalents and restricted cash at beginning of period 85,795 71,719 $ 71,719
Cash, cash equivalents and restricted cash at end of period 67,423 46,363 $ 85,795
Supplemental disclosure of cash flow information:      
Interest paid 1,060 1,094  
Payment for operating leases within operating activities $ 1,345 1,306  
Non-cash investing and financing activities:      
Deferred offering costs included in accrued expenses   $ 46